Your session is about to expire
← Back to Search
Insulin
Insulin for Type 1 Diabetes
Phase 4
Waitlist Available
Led By Gianna L Wilkie, MD
Research Sponsored by Gianna Wilkie
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at birth
Awards & highlights
Study Summary
This trial will compare two methods of insulin delivery for pregnant women with type 1 diabetes, to see if one is better at preventing adverse outcomes for the baby.
Eligible Conditions
- Type 1 Diabetes
- Pregnancies
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at birth
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at birth
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Neonatal Hypoglycemia
Secondary outcome measures
Apgar Score
Development of Diabetic Ketoacidosis during labor
Gestational age at delivery
+19 moreSide effects data
From 2015 Phase 4 trial • 156 Patients • NCT0200222113%
Nasopharyngitis
10%
Hyperhidrosis
9%
Hunger
9%
Tremor
8%
Asthenia
6%
Hypoglycaemia
1%
Squamous cell carcinoma of the tongue
1%
Femoral neck fracture
100%
80%
60%
40%
20%
0%
Study treatment Arm
Vildagliptin (LAF237)
Placebo
Trial Design
2Treatment groups
Experimental Treatment
Group I: Intravenous Insulin InfusionExperimental Treatment1 Intervention
Patients will be randomized to discontinuation of the CSII pump intrapartum and initiation of IV insulin infusion per hospital protocol.
Group II: Continuous Subcutaneous Insulin Infusion (CSII)Experimental Treatment1 Intervention
Patients will be randomized to continuation of their CSII pump intrapartum and will be managed in accordance with the CSII hospital protocol.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Insulin
2000
Completed Phase 4
~4280
Find a Location
Who is running the clinical trial?
Gianna WilkieLead Sponsor
1 Previous Clinical Trials
240 Total Patients Enrolled
Gianna L Wilkie, MDPrincipal InvestigatorUMass Memorial Health Care
2 Previous Clinical Trials
402 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does Insulin have any potential for harm?
"Insulin is a medication that has been approved, and thus, it is estimated to be safe with a score of 3."
Answered by AI
Does this research stand on its own, or has insulin been looked at before?
"At the moment, there are 80 different clinical trials underway that are studying Insulin. Of these active trials, 13 are in Phase 3. Most of the research being done on Insulin is taking place in Manhasset, New york, however, there are 257 medical centres across the globe running these sorts of studies."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger